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ABSTRACT
APPLICATIONS OF FLUORESCENCE DETECTED SEDIMENTATION
I.

STUDYING THE THERMODYNAMIC IMPACT OF VALENCE IN NON
IDEAL SOLUTIONS
II.
HIGH AFFINITY INTERACTIONS AND BIOLOGICAL MEDIA
By
Rachel R. Kroe
University of New Hampshire, December, 2005

The recent addition of the fluorescence detection optical system (FDS) to the
currently available absorbance and interference optical systems on the
analytical ultracentrifuge has greatly expanded the wide application of this
technique. The new FDS is able to detect very low concentrations of
fluorophore allowing the study of high affinity interactions (Kd ~ pM) not
previously accessible with the absorbance optics. The types of high affinity
interactions that can be explored include drug-protein interactions, lipid-receptor
interactions, DNA-protein interactions and protein-protein interactions. Selective
labeling of one or both of the macromolecules can allow elegant dissection of
complex assemblies. The only limiting factor is the researcher’s ability to label
the macromolecule of interest. In addition to high affinity interactions, selective
labeling of the macromolecule of interest with either a synthetic fluorophore or
GFP allows study of sedimentation, diffusion and association in complex
mixtures such as lysates, serum and other biological milieu. The use of FDS to
study of complex mixtures has application in both the pharmaceutical and food

ix
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science industries. Finally, the ability to study macromolecules under non-ideal
solution conditions will bridge what we know about macromolecular diffusion
and assembly under ideal conditions and what has been learned about diffusion
and assembly in the context of intact cells. New findings in this area will help to
build upon what is already known about macromolecular crowding and aid in
the refinement of current crowding theory.

Examples of the applications listed

above will be presented highlighting a diversity of systems and the power of this
exciting new advancement in analytical ultracentrifugation.

x
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CHAPTER I

INTRODUCTION

Most of our current understanding of biochemical equilibria, kinetics and
thermodynamics is based on measurements that have been made in idealized
solutions. Biochemists are trained to design experiments where the solution is
dilute, homogenous and well defined. While most biochemists will concede that
these conditions do not adequately describe the reality of biological media,
technological and theoretical limitations require these assumptions. There is a
growing interest in the scientific community to better understand the complexity
of biological media and its impact on biochemical equilibria and reaction rates
(Special Issue Jour. Mol. Rec). New technological advances currently
emerging in the field of biochemistry will play an important role in expanding our
understanding of this subject.

The cytoplasm of the cell and other biological media such as human plasma
differ greatly from the idealized solutions constructed by scientists in vitro.
Rather than being infinitely dilute, biological media contains a variety of
macromolecular species such as membranes, proteins, ribosomes, DNA and
RNA. While none of these macromolecules are individually present at high
concentrations, taken together they occupy approximately 20-30% of the

1
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volume of the cell (Hall, 2003; Minton, 1992). Due to this high macromolecular
content the inside of cells are often referred to as being ‘crowded’ or ‘volume
occupied’.

The crowded environment of biological media has affects on both the kinetics
and thermodynamics of the reactions occurring within the cell (Zimmerman,
1993; Hall, 2003). One effect of crowding is a reduction in the volume available
for diffusion. The volume available for each macromolecule to diffuse in will
depend on the size, number and shape of all the other molecules in the
solution. Diffusion rates in crowded solutions are also affected by non-specific
interactions that occur between various macromolecules along the diffusion
path. Types of interactions that can slow or speed diffusion include stericreplusive, hydrophobic, van der Waals and electrostatic. These types of non
specific interactions depend primarily on the global properties of the
macromolecules such as net charge, dipole moments, polarity of the surface
residues and macromolecular shape (Minton, 2001).

Current theories aimed towards describing the thermodynamics and kinetics of
molecules in crowded solutions have focused primarily on the role of size,
shape and steric-repulsive forces (Minton, 1998; Ellis, 2001). These theories
define each macromolecule in terms of the hard spherical volume that it
occupies in the cell. The volume available for each hard spherical
macromolecule to occupy in a crowded solution is defined as the fraction of the

2
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total volume that can be occupied by the center of that molecule. By this
definition the volume that each macromolecule can occupy will be less than the
total available volume in the solution. As a result the effective concentration of
each macromolecule will be much higher than the actual concentration in the
crowded medium. This increase in effective concentration will be greater for
large macromolecules than it is for small macromolecules. The extent to which
reaction rates and equilibria are altered by changes in effective concentration
ultimately will be dictated by the size of the interacting molecules.

The above theory is often referred to as excluded volume theory. Excluded
volume theory predicts that the crowded environment favors the formation of
complexes. Favorability is predicted based on calculations of activity
coefficients which can deviate from one by several orders of magnitude in
solutions of physiological levels of volume occupancy.

In practice, reaction

rates have been experimentally measured to improve by up to 2 to 3 orders of
magnitude in crowded solutions (Minton, 2001; Ellis, 2001). This enhancement
in interaction affinity is not only a function of the high effective concentration of
the macromolecules but also of the concomitant decrease in the total free
energy of the solution. Other cellular processes predicted to be favored in a
crowded environment include protein folding and the formation of inclusion
bodies (Berg, 1999).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Experimentally the effects of excluded volume have been measured using
methods such as tracer sedimentation equilibrium, fluorescence stopped-flow,
fluorescence recovery after photo-bleaching, vapor pressure osmometry and
freezing point depression. A tabulation of these studies can be found in reviews
by Hall (2003) and Zimmerman (1998). The experimental results from most of
these studies are consistent with predictions made by the excluded volume
theory.

However, in many of these studies the primary crowding agents are

neutral inert macromolecules such as polyethylene glycol (PEG) or Dextran
(Zimmerman 1998). Common proteins that are also used as crowding agents
include Ovalbumin, Bovine Serum Albumin, Hemoglobin, Lysozyme and
Ribonuclease. Interpretation of experimental results when proteins are used as
crowding agents typically ignore the physical properties of these molecules
such as net charge, dipole moments and surface polarity. The excluded
volume theory assumes that all interaction enthalpies are equivalent. In
practice it is commonly assumed that if working at physiological ionic strengths
that the contribution of enthalpy to solution non-ideality will be small as
compared to the entropy of the solution.

It remains, however, that very little

data exists on the role of charge in highly concentrated solutions.

The goal of this research is to examine the thermodynamic consequences of
non-specific charge driven interactions on macromolecular mobility and reaction
equilibria in high concentration solutions. Adding the second dimension of
valence to current crowding theories will bring us one step closer to being able

4
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to extrapolate the observations made in dilute solution to the context of a cell or
complete organism.

Towards our research goal a series of tracer sedimentation velocity
experiments has been designed in both high concentrations of a single
background macromolecule and real biological media. In tracer sedimentation
experiments a dilute macromolecular solute fluorescently or radioactively
tagged is centrifuged in a high background of crowding agent or biological
media (Rivas, 2003). The development of fluorescence detection (FDS) in the
analytical ultracentrifuge has greatly expanded the utility of this method.

In the

experiments presented here green fluorescent protein (GFP), Alexa488 labeled
bovine serum albumin (BSA) and Alexa488-lgG are used as tracer molecules.
The fluorescence optics allow us to monitor the sedimentation of a tracer
molecule independent of the complexity of the solution.

This research is divided into two parts. In the first part, experiments will be
discussed where a tracer molecule is sedimented in high concentrations of
background macromolecules of similar, opposite and neutral charge. The
second part of this work will explore additional applications of FDS including
sedimentation in biological media i.e. E. coli lysates and human serum.
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CHAPTER II

MATERIALS AND METHODS

Materials
Chemicals
Tris hydrochloride, Potassium Chloride (KCI), Sodium Chloride (NaCI), and
Ethylenediaminetetraacetic acid (EDTA) were purchased from Sigma.

Commercially Available Macromolecules
Hen egg white Lysozyme (L-6876, Lot 093K1455, E280 = 37,470 cm M"1, MW =
14,313 g mole'1), Ovalbumin (A7641, Lot 071K7094, E28o = 31,400 cm M'1, MW
= 42,750 g mole'1), Dextran (D9260, Lot 093K0709, MW = 8,500 - 11,500 g
mole'1), and Soybean Trypsin Inhibitor Type 1-S (T-9003, Lot 074K7009, E28o =
16,960 cm M'1, MW = 20,095 g mole'1) were purchased from Sigma. RNAse A
(78020Y, Lot 115588-017, E280 = 8,940 cm M'1, MW = 13,690 g mole'1) was
purchased from USB. Polyethylene Glycol 20,000 was purchased from
Avocado Research Chemicals (25322-68-3). The concentrations of protein
solutions were determined by measuring solution absorbance at 280 nm using
the molar extinction coefficients listed above. The concentrations of the
Dextran solutions were measured using a Reichert Abbe Mark II refractometer
and dn/dc = 0.15 ml/g.

6
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Expression and Purification of Green Fluorescent Protein (GFP)
The GFP clone was a kind gift from Dr. Eric Schaller (Dartmouth). This clone of
GFP contains multiple mutations (S65T, Q80R, F99S, M153T, V163A) and a
hexa-histidine tag followed by a thrombin cleavage site for removal of the HIStag after purification. A 11 tag follows the thrombin cleavage site. The clone is
inserted in a pET28a plasmid at the Sacl and BamHI restriction sites. Plasmid
DNA had been previously isolated by Jon Kingsbury in our laboratory and was
used to transform BL21 DE3 bacteria selecting for Kanamycin resistance. A
single colony was selected and used to inoculate a 25 ml culture of LB media
containing 100 pig/ml of Kanamycin (Bristol Laboratories). This culture was
grown at 37 °C overnight. A 2 liter flask containing 500 mis of LB media (3002075, BIO101, Inc), with 100 |^g/ml of Kanamycin was inoculated with 1 ml of the
25 ml culture and placed in a shaker at 37 °C. The OD of the culture was
monitored and at 0.5 OD the culture was induced with 1 mM Isopropyl p-DThiogalacto Pyranoside (IPTG) (I-6758, Sigma). The bacteria were harvested 5
hours after induction and stored at -20 °C.

The GFP was purified in batch mode using Qiagen nickel resin by a standard
method outlined in the Qiagen handbook. Briefly, the GFP pellet was thawed
on ice and suspended in a pH 7.9 buffer containing 10 mM Tris, 250 mM NaCI,
and 5 mM Imidazole (1-0125, Sigma). The solution was sonicated to lyse the
cells and centrifuged at 11,000 RPM for 20 minutes. The supernatant was
recovered after centrifugation and filtered through a 0.45 i^m sterile filter. The

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

filtered supernatant was then added to the Qiagen nickel resin and mixed on an
inversion mixer for 4 hours at 4 °C. The resin was then gently centrifuged and
washed 3 times with a pH 7.9 buffer containing 20 mM Tris, 500 mM NaCI, and
10 mM Imidazole. GFP was eluted from the resin with a pH 7.9 buffer
containing 20 mM Tris, 500 mM NaCI, and 1 M Imidazole. After elution the
protein was dialyzed exhaustively into a pH 7.5 buffer containing 10 mM Tris,
100 mM KCI and 0.5 mM EDTA. The concentration of GFP solutions was
determined using the molar extinction coefficient E2so = 21,890 cm M'1. The
sequence molecular weight of GFP is 30,838 g mole-1. The partial specific
volume of GFP has been measured experimentally in our lab (Sarah Bean,
Senior Thesis) and found to be 0.738 ml g"1.

Expression and Purification of Barstar
The Barstar gene was cloned into a pET22b plasmid using the Ndel and HindiII
restriction sites and transformed into BL21 DE3 (Gold) bacteria in the laboratory
of Dr. Edward Eisenstein (CARB). This clone of Barstar contains two mutations
(C40A and C82A) and a c-terminal hexa-histidine tag followed by a TEV
protease cleavage site for removal of the HIS-tag after purification. The Barstar
clone was given to our laboratory as a kind gift. Plasmid DNA was isolated
from the BL21 DE3 (Gold) bacteria using a QIAprep Spin Miniprep kit and
freshly transformed into BL21 DE3 bacteria selecting for Ampicillin resistance.
A single colony was selected to inoculate 500 ml of Novagen Overnight Express
Autoinduction media containing 100 pig/ml of Ampicillin and placed on a shaker

8
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at 37 °C. After 17 hours the bacteria were harvested and the pellet was stored
at -20 °C. A total of 5 Liters of culture was produced. Each Barstar pellet was
purified in batch mode using the same method as listed above for GFP. The
concentration of Barstar solutions was determined using the molar extinction
coefficient E2so = 22,460 cm M"1. The sequence molecular weight of Barstar is
12,180 g mole'1.

Recombinant soluble endothelial Protein C receptor (rsEPCR)
rsEPCR was a kind gift from Eli Lilly. The molar extinction coefficient of
rsEPCR is E28o = 29,910 cm M'1. The molecular weight of rsEPCR is 32,490 g
mole'1.

Antibodies
Anti-GFP(FL) rabbit polyclonal IgG (Santa Cruz, sc-8334), anti-GFP mouse
monoclonal IgG (Molecular Probes, A-11121), anti-GFP mouse monoclonal IgG
(Zymed, 33-2600), anti-GFP mouse monoclonal IgG (BD Biosciences, 8362-1)
and anti-GFP rat monoclonal IgG (MBL, D153-3) were purchased from vendors
as indicated.

Fluorescently labeled Lipids and Proteins
1-Palmitoyl-2{12-{(7-nitro-2-1,3-benzoxadiazol-4-yl) amino] dodecanolyl]-snGlycero-3-phosphocholine (DPPC-NBD) catalog number 810131 and 1,2Dioleoyl-sn-Glycero-3-Phosphoethanolamine-N-(Carboxyfluorescein (DPPE-

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Fluoroscein) catalog number 810332 were purchased from Avanti-polar lipids.
Alexa-488 BSA (A13100) and Alexa488-lgG (A11034) were purchased from
Molecular Probes.

Isolation of Human Serum and Plasma
Human blood (5 x 8mls) was collected into clot-activator tubes. The tubes were
centrifuged in a clinical centrifuge to pellet the red blood cells and
approximately 20 mis of serum was collected. Human blood (4 x10mls) was
also collected in tubes containing heparin. The tubes containing heparin were
centrifuged in a clinical centrifuge and approximately 30 mis of plasma was
collected.

Methods
Sedimentation Velocity (absorbance optics)
rsEPCR: Sedimentation velocity data was collected for 14 uM rsEPCR
at 20°C in a pH 7.5 buffer containing 20 mM Tris, 100 mM NaCI and 3 mM
CaCh. Data was collected at 60,000 rpm using an 4-hole An60 Ti rotor. The
sample was loaded into a SEDVEL60K centerpiece with quartz windows. Data
was collected at 280nm.

Fluorescence Detection System (FDS) Instrumentation
Lasers: Experiments conducted prior to November 11, 2004 (See
Appendix IX for dates of experiments) were performed using a Novalux Proterra

10
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laser. The Novalux laser has a peak wavelength in the range of 486-490 nm
with an output power of 15 mW. The protective coating on the base infared
Novalux laser was found to be highly sensitive to IR degradation under vacuum.
As a result the majority of data collected with these lasers were collected at an
output of 10 mW or less. When necessary, the power output was adjusted by a
manual reconfiguration. Use of the Novalux laser was abandoned in November
of 2004 and the switch was made to the Picarro Cyan laser. The Picarro laser
has a wavelength of 488 nm +/- 0.5nm and varying output powers. Most units
have an output power of approximately 10 mW.

Filters: The FDS optics prior to April 21, 2005 was configured such that
the excitation light would pass through an assembly of lenses and then through
a 100 pm spatial filter. Emitted light was detected by a PMT after passing
through 490 nm high pass cut-off filter and a 600 pm spatial filter. After April
21, 2005 the spatial filter on the PMT side was reduced to 100 pm and the 490
nm filter was replaced with a 500 nm cut off filter. Reducing the size of the
pinhole in the spatial filter and changing the cut off filter reduced the detected
background signal and greatly improved the quality of data collected.

Photomultiplier Tube (PMT): The PMT used to detect the fluorescence
emission signal is a Hamamatsu H6779-04. The sensitivity of each PMT varies
from unit to unit. Unfortunately, the specific PMT installed in the FDS optics
was not tracked over the course of these experiments. Therefore the values

11
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below represent the best and worst case scenarios. The sensitivity of a PMT is
determined by three parameters; cathode luminous sensitivity, anode luminous
sensitivity and anode dark current. The cathode luminous sensitivity is a
measure of the efficiency of the PMT to convert photons into electrons. The
cathode luminous sensitivity range for the PMTs used in the various
development optics ranges from 9 9 - 1 9 6 A/lm. The anode luminous sensitivity
is a measure of the output current of the PMT after the secondary electron
emission, also referred to as the gain. The gain on the various PMTs used in
the development optics ranges from 54.7 -113 pA/lm. The anode dark current
is a measure of the current from the PMT when there are no incident photons.
This is referred to as the ‘noise’ on the PMT. The background noise of the
various PMTs ranged from 0.31 - 1.4 nA.

Software: Data collected prior to 2005 was collected using the beta
version of the FDS software. Data collected after 2004 was collected with
versions 1 through 1.932. The specific version used for each experiment was
not tracked.

FDS Sedimentation Velocity
FDS of GFP in the presence of varying concentrations of background
molecules (Dextran. Soybean trypsin inhibitor and hen egg white Lvsozyme):
Fluorescence detected sedimentation velocity studies were carried out at 20°C
in a pH 7.5 buffer containing 10 mM Tris, 100 mM KCI and 0.5 mM EDTA. Data

12
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was collected at 50,000 rpm using an 8-hole An50 Ti rotor. Samples were
loaded into both the sample and reference sides of double sector SEDVEL60K
or Beckman charcoal-filled epon centerpieces. For experiments where HEL
and STI served as background material, data was collected for 40 nM GFP in
background concentrations ranging from 0.75 to 50 mg ml'1. For the Dextran
experiments data was collected for 40 nM GFP in background concentrations
ranging from 0.07 to 35.3 mg ml'1. All background molecules were dialyzed
exhaustively against buffer prior to the addition of GFP. Both quartz and
sapphire windows were used.

Data was analyzed using SEDFIT version 8.9 (available online at
www.analvticalultracentrifuqation.com, Schuck, 2000). The data were fit with
multiple models including the non-interacting discrete species model,
continuous c(M) model and the continuous c(s) model. The details of how each
of these fits was performed are indicated below. Data fits for GFP sedimenting
in dextran, STI and HEL were first performed using the non-interacting discrete
species model fitting for Sapp, Dapp, Capp, time-independent (TI) and radially
invariant (Rl) noise. For each fit 68.3% confidence intervals were calculated,
using the sedfit software, for both Sapp and Dapp fit values. Apparent S and D
values were corrected to S2o,w and D2o,w values using measured density and
viscosity values as reported in appendices III and IV. A second fit to the data
was performed using the continuous molar mass distribution model. For these
fits the density of the solution, the viscosity of the solution and the partial
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specific volume of GFP were specified. The experimental data was fit with a
resolution of 100 over a range of 10,000 to 100,000 g mol'1 fitting for TI and Rl
noise allowing the f/f0 ratio to float. Monte Carlo analysis using 100 simulations
over an integrated weight average range of molecular weight values was
performed to estimate the error on the fit molecular weights from these
analyses. The ratio of apparent concentration to the true concentration, the
activity of the solution, was calculated and the ratio of the sequence molecular
weight of GFP divided by the fit molecular weight.

Data fits were also performed using the continuous c(s) model. The
experimental data were fit with a resolution of 100 over a range of 0.5 to 6 S
fitting fo rT I and Rl noise. Monte Carlo analysis using 100 simulations over an
integrated weight average range of S values was performed to estimate the
error on the fit sedimentation coefficients from these analyses.

FDS of DPPC-NBD in the presence and absence of rsEPCR:
Fluorescence detected sedimentation velocity studies were carried out at 20°C
in a pH 7.5 buffer containing 20 mM Tris, 100 mM NaCI and 3 mM CaCb- Data
was collected for 400 nM NBD-DPPC in 10, 5, 2.5 and 1.25 ^M rsEPCR at
60,000 rpm using an 4-hole An50 Ti rotor. Samples were loaded into both the
sample and reference sides of double sector SEDVEL60K centerpieces with
sapphire windows. The data were fit using Sedfit version 8.9 using both the
continuous c(s) distribution and non-interacting discrete species models fitting

14
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for Tl and Rl noise. Error analysis was performed on the discrete species fits
calculating the 68.3% confidence intervals for the Sapp fit value.

FDS of GFP and Anti-GFP: Anti-GFP (MBL) was dialyzed against a pH
7.5 buffer containing 10 m M T ris, 100 mM KCI and 0.5 mM EDTA at 4 °C to
remove the 50% glycerol from the antibody solution. After dialysis the antibody
was serially diluted 1:3 into buffer covering an antibody concentration range of
540 to 0.003 nM. A concentration of 40 nM GFP was added to each of the
antibody dilutions. Cells were assembled with double sector charcoal-epon and
SEDVEL60K centerpieces with either quartz or sapphire windows. Data were
collected at 20 °C and 50,000 rpm in an 8-hole An50 Tl rotor. The data were fit
using SEDFIT version 8.9 using the continuous c(s) distribution fitting for Tl and
Rl noise. Monte Carlo analysis using 100 simulations over an integrated weight
average range of Sapp values was performed to estimate the error on the fit
sedimentation coefficients from these fits.

FDS of Alexa488-BSA and Alexa488-lqG: Alexa488-BSA was re
suspended into a pH 7.5 buffer containing 10 mM Tris, 100 mM KCI and 0.5
mM EDTA. Data was collected at 20 °C and 50,000 rpm in a 8-hole An50 Ti
rotor for 500 nM Alexa488-BSA in buffer, 1.4 nM Alexa488-lgG in buffer, 100
nm Alexa488-BSA in human serum and plasma and 100 nM Alexa488-lgG in
human serum and plasma. Cells were assembled with quartz windows and
either double sector charcoal-epon or SEDVEL60 centerpieces. The data were

15
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fit using SEDFIT version 8.9 using the continuous c(s) distribution fitting forT I
and Rl noise. Monte Carlo analysis using 100 simulations over an integrated
weight average range of Sapp values was performed to estimate the error on the
fit sedimentation coefficients from these fits.

FDS of GFP in serum: GFP was spiked into human serum at GFP
concentrations ranging form 540 to 4 nM. In a second set of experiments,
human serum was serially diluted 1:2 in buffer from 100% to 0.05% at a
constant concentration of 40 nM GFP (data not discussed). Data was collected
at 20 °C and 50,000 rpm in a 8-hole An50 Ti rotor. The cells were assembled
with double sector charcoal-epon centerpieces and quartz windows. The low
concentration GFP data were fit using SEDFIT version 8.9 using both the
continuous c(s) distribution fitting fo rT I and Rl noise.

FDS of GFP and anti-GFP in serum: Equal concentrations (100 nM) of
GFP and anti-GFP (MBL) were spiked into human serum. Data was collected
at 20 °C and 50,000 rpm in a 8-hole An50 Ti rotor. The cells were assembled
with double sector charcoal-epon centerpieces and quartz windows.

The low

concentration GFP data were fit using SEDFIT version 8.9 using both the
continuous c(s) distribution fitting fo rT I and Rl noise. Monte Carlo analysis
over an integrated weight average range of Sapp values was performed using
100 simulations to estimate the error on the fit sedimentation coefficients.
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FDS of fluorescein-DPPE in serum: Human serum was spiked with
either 4 pM or 2 pM fluorescein-DPPE. Data was collected at 20 °C and 50,000
rpm in a 8-hole An50 Ti rotor. The cells were assembled with double sector
charcoal-epon centerpieces and quartz windows. The data shown in chapter 4
is at the 4 pM concentration.

FDS of GFP in E.Coli Lysates: The E. Coli lysates used in these
experiments were obtained during the purification of Barstar (see above). For
these experiments the bacteria were lysed in a pH 7.9 buffer containing 20 mM
Tris, 500 mM NaCI, and 10 mM Imidazole. After sonication the lysate was
dialyzed overnight at 4 °C into a pH 7.5 buffer containing 10 mM Tris, 100 mM
KCI and 0.5 mM EDTA. After dialysis, the total protein concentration of the
lysate was measured using a Biorad protein assay (catalog # 500-0002) and
found to be 6.8 mg/ml. A concentration of 20 nM GFP was spiked into various
dilutions of the E. Coli lysate ranging from 6.8 to 0.1 mg/ml total protein
concentration. Data was collected at 20 °C and 50,000 rpm in a 8-hole An50 Ti
rotor. The cells were assembled with double sector charcoal-epon centerpieces
and quartz windows. The data were fit using Sedfit version 8.9 using the
continuous c(s) distribution fitting fo rT I and Rl noise.

Fluorescence Polarization: For the polarization experiment the
concentration of the anti-GFP (MBL, D153-3) was determined using a Biorad
protein assay (catalog # 500-0002). The experiment was set up in the 96-well
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Dynex (#7005) round bottom low-binding black polystyrene plate. Anti-GFP
was added to the first two wells of rows 1-2 at a concentration of 2 pM and
serially diluted across the plate 1:2 in 100 pi of a pH 7.5 buffer containing 10
mM Tris, 100 mM KCI and 0.5 mM EDTA. Next, 100 pi of a 2 nM GFP stock
solution in the same buffer was added to all of the wells such that the final
concentration of GFP in all the wells was 1 nM. The concentration of the
antibody ranged from 1 pM to 200 pM. Fluorescence polarization was
measured using an LJL platereader (Ex 485 nm, Em, 530 nm) with a 561 nm
dichroic mirror installed. The data were fit using a program written in SAS for
fitting direct one site binding fluorescence polarization data.

18
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CHAPTER III

GFP AS A PROBE OF NON-IDEALITY IN HIGH CONCENTRATION
BACKGROUNDS

Introduction and Theory
The colligative properties of a solution provide a measure of the chemical
potential of the solvent in the solution relative to that of pure solvent (Tanford,
1961). Osmotic pressure, vapor pressure, freezing point depression and boiling
point elevation are all colligative properties. Experimentally these properties
can be used to determine the molecular weight of the solute. In particular,
osmotic pressure (n) can be used for determining the mass of solute molecules
such as proteins. Typically this is done by measuring osmotic pressure at
several concentrations

(C b )

of the macromolecule and constructing a plot of

n/Ce versus CB. In this type of plot, the reciprocal intercept on the y-axis yields
a value for the apparent molecular weight of the macromolecule. Measurement
of the colligative properties of a solution, such as osmotic pressure, captures
the sum effect of all the forces present in a solution (Tanford, 1961). As
solutions become more concentrated, effects such as excluded volume, chargecharge interactions, dipole interactions, and surface polarity will alter solution
properties causing them to behave non-ideally. For this reason, extrapolation to
an infinitely dilute solution is required to acquire a precise value for the
macromolecule’s molecular weight.
19
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Mathematically, deviations from ideality are taken into account by writing a virial
expansion of the van’t Hoff equation:

11 = R T { — + B c
cB
km b

)

(1)

where n is the osmotic pressure, Cb is the molar concentration, R is the gas
constant, T is the temperature, MB is the molecular weight and B is the second
virial coefficient. The second virial coefficient describes the non-ideality of the
solution.

Experimentally, the second virial coefficient is measured as the slope

of a n/C B versus CB plot, which for an ideal solution would be zero. Deviations
from zero slope can be either positive or negative depending on the nature of
the forces present in the solution. If the interactions between the solution
components are primarily repulsive, the value of B will be positive. If the
components in the solution are associating and/or other weak favorable
interactions are occurring in the solution, the value of B will be negative.

While measuring the osmotic pressure of a solution directly provides the sum
value of B, the contributions of factors influencing deviations from ideality can
be estimated mathematically. The contribution of excluded volume can be
estimated using equation 2:

* =^

3M\

(2)
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where N is Avogadro’s nu m be r, r is the radius of the macromolecule and MB is
the molecular weight of the molecule (Tanford, 1961). The contribution of
charge-charge interactions can be estimated using equation 3:

B = ^

T

4M2
bc

(3 )

where z is valence, MB is molecular weight and c is concentration (Tanford,
1961). This value is also referred to as the Donnan term.

The predicted osmotic pressure of concentrated macromolecule solutions can
be calculated using equation 1 taking into account the contributions of excluded
volume and charge to the second virial coefficient. The impact of these two
forces on the solution properties can be visualized by constructing a graph of
Capp/C versus concentration; where Capp is the concentration calculated from

the predicted osmotic pressure and C is the true concentration of the
macromolecule solution. The ratio of Capp/C is often referred to as the ‘activity’
of a solution. The squares in Figure 1 show the expected ratio of Capp/C for an
ideal solution. In an ideal solution the measured concentration will always
reflect the absolute concentration of the solution. The diamonds in Figure 1
show the calculated effect of both excluded volume (Equation 2) and chargecharge interactions (Equation 3) on the activity of hen egg white Lysozyme
(HEL) in a buffer at physiologically relevant ionic strength (0.11 M) and pH (7.5).
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Figure 1: Predicted effect of excluded volume (circles) and charge (triangles)
on the total (diamonds) activity of HEL in high concentrations of HEL.

As a result of excluded volume and charge-charge interactions the activity of
the HEL solution is predicted to increase as the concentration of HEL increases.
The extent to which this increase is influenced by excluded volume and charge
are shown by the circles and triangles respectively. It can be seen that the
contribution of charge-charge repulsion to solution non-ideality is greater than
the contribution of excluded volume. This graph shows that charge-charge
repulsion is a significant force contributing to the non-ideality of high
concentration solutions at physiologically relevant salt concentrations.

The goal of this research is to experimentally characterize the impact of non
specific charge-charge interactions that occur in concentrated solutions. To

22
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address this goal a series of tracer sedimentation velocity experiments were
constructed using the fluorescence detection system in the analytical
ultracentrifuge. In these experiments GFP is sedimented in concentrated
solutions of anionic, cationic and neutral macromolecules. Tracer
sedimentation provides a means of measuring changes in the apparent
molecular weight of the GFP and thus the activity of the solution that occurs as
a result of the non-ideality of high concentrations of macromolecules of varying
charge.

The sedimentation velocity data discussed in this research has been fit using
several different models. At this time it is not clear how to best fit tracer
sedimentation velocity data in concentrated solutions. Future analysis of this
data with more appropriate fitting models will likely provide clearer insight into
both the hydrodynamic and thermodynamic phenomena occurring in these
solutions.

Results
The choice of biological standards to be used as background macromolecules
was based on several criteria. First, the background macromolecules must
have a mass less than that of the tracer molecule in order to avoid the
manifestation of Johnston-Ogston effects in the sedimentation velocity data
(Johnston, 1946; Correia, 1976). The choice of similar molecular weight
background macromolecules also allows the phenomena observed in the
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sedimentation velocity data to be explained primarily in terms of valence.
Second, the background macromolecules should be well characterized and
soluble enough to work with at high concentrations. Finally, it is important that
the background macromolecules are not prohibitively expensive to work with in
hundred’s of milligram quantities.
Based on the above considerations, HEL, Soybean Trypsin Inhibitor (STI) and
Dextran were selected to be used as background macromolecules. The
valence of HEL, STI and GFP at pH 7.5 have been measured in our laboratory
and found to be z = +6.1 +/- 0.1, z = -8.6 +/- 0.3 and z = -6.4 +/- 0.3 respectively
(Sue Chase unpublished). Details of the measurement of the Stoke’s radius for
two of these macromolecules, used for the calculation of valence, can be found
in Appendix I. Dextran is a neutral (z = 0) macromolecule.

Prior to conducting experiments in concentrated solutions the sedimentation of
GFP was characterized in dilute solution. The c(s) distribution for GFP at low
concentration (40 nM) in buffer is shown as the green line in Figure 2. These
data were collected using the FDS optics and fit to a S 2 o,w of 2.87 (2.85, 2.89)
and a molecular weight of 31,107 (31,072 - 31,113) g mole'1. These results are
consistent with GFP being a monomeric protein. GFP was also sedimented at
higher concentrations (pM) using the absorbance optics. The absorbance data
fit to a S2 o,w of 2.90 (2.89, 2.91) and a molecular weight of 31,050 (30,842 31,219).
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To explore the role of valence in concentrated solutions anionic GFP was first
sedimented in solutions containing various concentrations of the neutral
macromolecule Dextran. Collecting data using a neutral macromolecule
provides a baseline for the contribution of excluded volume to the non-ideality of
these solutions. The grey line in Figure 2 shows the c(s) distribution for GFP
sedimenting in a background of 35 mg ml'1 Dextran. The cartoon in the upper
left hand side corner of Figure 2 illustrates the solution conditions. The molar
concentration of Dextran ranges from 150 to 88,250 fold greater than GFP. The
data show that the apparent sedimentation of GFP is slowed in the presence of
Dextran.
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Figure 2: The apparent sedimentation of GFP in dilute solution (green) and in a
background of 35 mg ml'1 Dextran (grey) in 10 mM Tris pH 7.5, 100 mM KCI,
and 0.5 mM EDTA at 50,000 rpm and 20 °C.
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The decrease in the apparent sedimentation of GFP is concentration dependent
as shown in Figure 3. Correcting the apparent sedimentation coefficients using
measured density and viscosity values (Appendix III and IV) reveals similar
S2o,w values at each concentration of Dextran (Figure 4). This would suggest

that the shift in sedimentation coefficient is primarily a hydrodynamic effect
resulting from the increased viscosity and density of the 35 mg ml'1 Dextran
solution. A similar phenomenon is observed when GFP is sedimented in a 50
mg ml"1 solution of PEG 20K and is discussed in Appendix II.

c
0)
o
0)

o

o
c
o
"S
c
v

oc

2 .6

-

2 4 -

E
©

C/)
ca>

2 .2 -

2 . 2.0 -

Q.

<

0

10

20

30

40

50

Concentration Background Molecule [mg/ml]

Figure 3: The apparent sedimentation coefficient of GFP in Dextran (squares),
STI (circles) and HEL (triangles) as function of background molecule
concentration in 10 mM Tris pH 7.5, 100 mM KCI, and 0.5 mM EDTA at 50,000
rpm and 20 °C. Data has not been corrected for solution density or viscosity.
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Diffusion coefficients (D) also were fit and are shown as D2o,w values in Figure
4. The error on the diffusion coefficient is significantly greater than the error on
5. This is expected as it is more difficult to precisely fit for boundary spreading
as compared to the midpoint of the boundary; however, some of the error in D
is contributed in part by sub-optimal laser focus. The ratio of S 2o,w/D2o,w> also
plotted in Figure 4, is an indication of the trend in the apparent molecular weight
of GFP as a function of Dextran concentration. The apparent molecular weight
appears to remain constant throughout the concentrations of Dextran tested.
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Figure 4: Calculated S2o,w (black circles), D2o,w (blue squares) and ratio
S 2o,w/D2o,w (red triangles) of GFP as a function of Dextran concentration.

In the next set of experiments, data was collected to explore the effect of high
concentrations of a background macromolecule of similar charge to GFP. In
these experiments STI was used in place of Dextran. These experiments were
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designed such that GFP would sediment in a nearly constant enthalpic bath.
Figure 5 shows the c(s) distribution of GFP in 50 mg ml'1 of STI. As seen in the
Dextran solution, the sedimentation of GFP is slowed in high concentrations of
STI (Figure 3). The sedimentation of GFP was measured in STI solutions
covering molar concentrations ranges from 435 to 62,200 fold in excess of the
concentration of GFP. The reduction in apparent sedimentation coefficient was
shown to be concentration dependent (Figure 3). Similar phenemona of GFP
sedimentation has also been observed using Ovalbumin as the anionic
background molecule and is discussed in Appendix II.
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Figure 5: The apparent sedimentation of GFP in dilute solution (green) and in
50 mg ml'1 STI (red) in 10 mM Tris pH 7.5, 100 mM KCI, and 0.5 mM EDTA at
50,000 rpm and 20 °C.
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Correction to S2o,w values reveal a fairly constant value (Figure 6) suggesting
that the shift in sedimentation coefficient is primarily a hydrodynamic effect. In
contrast to the Dextran results, the D2o,w value decreases as the concentration
of STI increases. This decrease in D results in a small increase in the ratio of
S 2o ,w /D 2o,w

and thus a proportional increase in the apparent molecular weight of

G F P at high STI concentrations.
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Figure 6: Calculated S2o,w (black circles), D20,w (blue squares) and ratio
S 2o,w/D2o,w (red triangles) of GFP as a function of STI concentration.

The third set of experiments examines how high a background concentration of
a macromolecule of opposite charge affects GFP sedimentation. In these
experiments HEL was used as the background macromolecule. Figure 7 shows
the c(s) distribution for GFP in 50 mg ml'1 HEL. Contrary to what is seen in the
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neutral or same charge solutions the sedimentation of GFP is unchanged in the
HEL backgrounds (Figure 3). Conversion to S 2o,w values shows that the
sedimentation coefficient is increasing in the HEL solutions (Figure 8). Since
similar phenomena was not observed in the Dextran and STI solutions it is
unlikely that the increase in sedimentation coefficient is arising from simple
hydrodynamic non-ideality or excluded volume. Instead, these data suggest
that GFP may be co-sedimenting with the HEL as depicted in the cartoon in the
upper left hand side of Figure 7. Similar to what was seen in the STI solutions
the diffusion coefficient for GFP is shown to decrease as the concentration of
HEL increases (Figure 8). The decrease in diffusion coefficient coupled with
the increase in sedimentation coefficient results in a significant increase in
apparent molecular weight of GFP in these solutions.
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Sedimentation Coefficient

Figure 7: The apparent sedimentation of GFP in dilute solution (green) and in
50 mg ml'1 HEL (blue) in 10 mM Tris pH 7.5, 100 mM KCI, and 0.5 mM EDTA at
50,000 rpm and 20 °C.
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Figure 8: Calculated S2o,w (black circles), D20,w (blue squares) and ratio
S 2o ,w /D 2 o ,w

(red triangles) of GFP as a function of HEL concentration.

This phenomenon has also been observed sedimenting Alexa488-BSA
(anionic) in backgrounds of Ovalbumin (anionic), HEL (cationic) and Dextran
(neutral) as discussed in Appendix V. The fact that similar observations have
been made with both GFP and Alexa488-BSA suggest that the observed effects
of valence may be generally applied and may not be unique properties of our
choice of tracer or background molecules.

In order to better quantify the changes in the apparent molecular weight of GFP
in the various solutions, the data were fit to a continuous c(M) distribution model
taking both viscosity and density of the solutions into account. The apparent
molecular weights obtained as the peak in the c(M) distributions from these fits
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were used to calculate the activity of each solution. In Figure 9, the activity of
each of the solutions is plotted as a function of background macromolecule
concentration. The activity of GFP in the Dextran solutions appears to be
constant over the concentration range tested. Interestingly, the activity of GFP
in both the 50 mg ml'1 STI and HEL is shown to decrease. This suggests the
presence of weak attractive forces in these solutions.
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Figure 9: The activity of GFP as function of Dextran (Black squares), STI (red
circles) and HEL (green triangles) concentration ) in 10 mM Tris pH 7.5, 100
mM KCI, and 0.5 mM EDTA.

The Sedfit software allows the user to fit for the ratio of f/fo, where f is the
frictional coefficient of the molecule being sedimented and fo is the frictional
coefficient of a smooth compact sphere. The ratio of f/f0 provides information
about the shape of the GFP and the extent to which it is solvated. The ratio of
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f/f0 was allowed to float in the c(M) fits. A graph of f/f0 versus concentration of
background molecules for GFP in each of the background solutions is plotted in
figure 10. The ratio of f/f0 is constant in the Dextran solutions. In the HEL
solution the ratio of f/f0 for GFP increases as function of HEL concentration. An
increase is also observed in high concentrations of STI.

One interpretation of

these data is that the increase in f/f0 is indicative an increase in the Stokes
radius of the GFP. The increase in f/f0 may also represent the extent to which
the sedimentation of GFP is coupled to the sedimentation of the background
molecule.
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Figure 10: Ratio of f/f0 for GFP in Dextran (black squares), STI (red circles) and
HEL (green squares).
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Discussion
As introduced earlier, predictions of the non-ideality of a solution can be
calculated using the virial expansion of the van’t hoff equation. Similar
calculations can be made to estimate the impact of excluded volume and
charge-charge interactions occurring between the tracer molecule and the
background molecules. Figure 11 shows the predicted impact of excluded
volume and charge-charge non-ideality on the activity of GFP in each of the
background solutions. Taking the solution non-ideality into account the van’t
hoff equation predicts there to be little effect of high concentrations of Dextran
on the activity of the GFP solutions. The experimental data confirm this
prediction. Similar calculations made for the HEL solutions predict the
decrease in activity measured for GFP in the HEL solutions. However, the
predicted decrease in activity is not as great as what is measured
experimentally. The shortcomings of these predictions become most obvious
when a comparison is made between the predicted activity of GFP in the STI
backgrounds and what is experimentally measured. The van’t hoff equation
predicts that the activity of GFP to increase in the STI solutions, however a
decrease is measured. Experimentally, the data for GFP in the HEL and STI
solutions show that predictions made based on excluded volume and charge
alone do not account for all of the phenomena occurring in these high
concentration solutions.
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Figure 11: Calculated impact of solution non-ideality on the activity of GFP in
Dextran (black line), STI (red dotted line) and HEL (green dotted line) as
compared to experimentally measured values in Dextran (black squares), STI
(red circles) and HEL (green triangles).

One possible explanation for the measured decrease in GFP activity could be
that the GFP is forming a dimer. The model used for calculations made with the
van’t hoff equation does not include the potential for dimer formation. However,
GFP dimerization seems unlikely since there was no evidence of GFP
dimerization in the sedimentation velocity experiments conducted at pM
concentrations. In addition the data fit well to a single species model with no
indication of an interaction boundary. Finally, if dimer formation were favored
due to excluded volume effects, we would expect to see it in the Dextran
solutions as well.
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In our analysis we are considering the background molecules as having a single
evenly distributed charge. In reality, these macromolecules have patches of
charge that vary across the surface. It is possible that STI has a cationic patch
that favorably interacts with the GFP at the higher concentrations. In fact,
inspection of the electrostatic surface of the STI crystal structure shows a
cluster of 3 cationic residues. The fact that GFP appears to co-sediment with
STI at high concentrations may reflect the relative non-ideality of interactions
between STI and itself as compared to interactions with GFP. Since STI is
more highly charged than GFP, it will be more favorable for STI to co-sediment
with GFP relative to another STI molecule.

It is also possible that the effect

seen in the STI solution is the result of another type of interaction driven by
dipole moment or surface polarity. Additional favorable interactions such as
these may also explain why the measured activity of GFP in the HEL solutions
is greater than what is predicted.

Table 1 (reproduced from Matthews and van Holde) contains a list of all of the
types of non-covalent interactions that can occur in solution. Charge-Charge
interactions occur over the longest range distance and are the dominant forces
at low to moderate concentrations. However, as solutions become more
concentrated molecules will be more closely packed thus increasing the
probability for other interactions such as charge-dipole, dipole-dipole and
hydrogen bonding to occur. All of these interactions are favorable and would
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result in a decrease in the activity of the solution. Our calculations using the
van’t Hoff equation do not take into account these additional favorable forces.
The data suggest that these additional forces have a significant impact on the
measured non-ideality of concentrated solutions.
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Table 1: Non-covalent Interactions
Type of Interaction

Model

Dependence
of Energy on
Distance

Charge-Charge
(Longest-range force,
non-directional)

1/r

Charge-Dipole
(Depends on
orientation of the
dipole)
Dipole-Dipole
(Depends on mutual
orientation of dipoles)

1/r2

1/r3

Charge-Induced Dipole
(Depends on the
polarizability of the
molecule in which the
dipole is induced)
Dipole-Induced Dipole
(Depends on the
polarizability of the
molecule in which the
dipole is induced)
Dispersion
(Involves mutual
synchronization of
fluctuating charges)

1/r4

1/r5

1/r6

Van der Waals
Repulsion (occurs
when outer electron
orbitals overlap)
Hydrogen Bond
(Charge attraction +
partial covalent bond)

1 / r 12

Length of bond
fixed
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The data generated thus far show that valence is a significant driving force for
non-specific interactions in complex media. Experiments conducted where
tracer molecules are dissolved in solutions containing high concentrations of
macromolecules of defined charge show that the tracer molecule preferentially
sediments with macromolecules of opposite charge. The data also show that
as solutions become more concentrated the role of short-range non-covalent
interactions becomes significant. More importantly these data highlight the
need to consider not only the entropic but also the enthaplic forces present in
high concentration solutions. An understanding of high concentration solutions
is necessary to better understand the forces and organizing principles in
complex media such as serum and cell lysates.

The addition of fluorescence optics to the analytical ultracentrifuge has
expanded our ability to study the sedimentation in complex and concentration
solutions. Future work will be aimed towards gaining a better understanding of
the role of charge and weak attractive forces in concentrated solutions through
use of the sedimentation equilibrium method. Sedimentation equilibrium data
will allow us to dissect the features of the data that are the result of
hydrodynamic non-ideality from thermodynamic non-ideality.
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CHAPTER IV

APPLICATIONS OF FDS

One of the primary advantages to using fluorescence optics over either the
absorbance or interference optics in the analytical ultracentrifuge is sensitivity.
The fluorescence optics can detect fluorophores over a concentration range
covering 6 to 8 logs. The lower limit of detection is dictated by multiple factors
including the power of the lightsource (laser), the sensitivity of the photo
multiplier tube (PMT) and the quantum yield of the fluorophore. If all of these
factors are optimized, fluorophore concentrations in the pM to fM level can
easily be detected (MacGregor, 2004; Laue, 2004). The ability to study the
sedimentation behavior of macromolecules at such low concentrations enables
experimenters to study high affinity interactions previously inaccessible with
either the absorbance or interference optical systems. Examples of the
application of FDS to study high affinity interactions will be discussed in this
chapter (see examples 1-2).

The second major advantage to using fluorescence optics in the analytical
ultracentrifuge is the ability to selectively monitor the sedimentation of a single
component in a solution. Experiments of this type are often referred to as tracer
sedimentation (Rivas, 2003). Tracer sedimentation can be applied to simple
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two-component systems as discussed in example 1 as well as to highly
complex systems such as the sedimentation of a macromolecule in serum or
cell lysates. In this chapter several examples of the application of FDS to
selectively monitor sedimentation in complex solutions will be discussed
(examples 3-8).
When designing experiments to be conducted with the fluorescence optics the
experimenter chooses to label the macromolecule of interest either chemically
with a dye (Alexa488, fluorescein, Oregon green) or genetically by preparing a
GFP fusion protein.

In all cases control experiments should be done to confirm

that the labeling procedure has not altered the physical properties of the
macromolecule. This is most easily done by conducting competition
experiments with an unlabeled version of the macromolecule of interest.
Another concern when working with fluorescence is photo-bleaching. The
sensitivity of the labeled macromolecule to photo-bleaching over the timecourse of the sedimentation experiment should be characterized and taken into
account when analyzing data. Photobleaching of GFP and Alexa488, the two
fluorophores discussed in this chapter, has not been exhaustively studied.
However, it was generally not found to be a problem.

The experiments presented in this chapter were performed using FDS detectors
and software in various states of development. There have been several
designs of fluorescence detectors for the analytical ultracentrifuge over the
years (MacGregor (2004) and therein). Brief details of the detectors used in

42

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

these studies are covered in chapter 2. A complete description of the latest
detector will be covered elsewhere (Laue, Austin, Rau in press and in
preparation).

As a final note, all of the work covered in this chapter is still in progress. The
goal of this chapter is to highlight the use of the fluorescence optics and to
discuss future steps needed to take full advantage of FDS in the analytical
ultracentrifuge.
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Use of FDS to Study Small Molecule-Protein Interactions

Example 1: Studying the interaction between rsEPCR and DPPC/E
Introduction:
The interaction between a soluble recombinant form of the endothelial protein C
receptor (rsEPCR) and both activated and non-activated protein C have been
previously characterized in our laboratory by analytical ultracentrifugation
(AUC). In these studies it was shown that non-activated protein C and rsEPCR
interact with a 1:1 stoichiometry and a Kd = 2.0 +/- 0.9 pM (n = 8) in solution
(unpublished, Kroe MSc 1998). The interaction between rsEPCR and activated
protein C was shown to be slightly weaker with a Kd = 6.0 +/- 0.6 pM. Both
interactions were shown to be calcium dependent with no further enhancement
in binding with the addition of magnesium. The interaction between rsEPCR
and thrombomodulin was also investigated and shown not to directly contribute
to protein C binding.

EPCR shares a high level of homology with both the major histocompatibility
complex (MHC) class 1 and cell differentiation (CD1) family of molecules. Both
MHC class 1 and CD1 molecules function to present antigens, either peptide or
lipid, to the immune system. The crystal structure of rsEPCR both bound to the
gla-domain of protein C and in its unbound form have recently been solved
(Oganesyan etal., 2002). Interestingly, these structures revealed a bound
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phospholipid present in the binding groove. This finding is consistent with the
homology between EPCR and MHC class 1 and CD1 family molecules.

Oganesyan and co-workers have suggested that the interaction between
protein C and EPCR is dependant on bound phospholipid and that the
lipid:rsEPCR interaction is high affinity.

Earlier work performed in Chuck

Esmon’s laboratory measured a Kd = 30 nM for the interaction between EPCR
and activated protein C (Fukudome etal., 1996). This value was achieved by a
competitive binding flow cytometry assay that measures direct binding of
activated protein C to the cell surface.

The apparent discrepancy between the solution centrifugation studies and the
flow cytometry assay would suggest that the addition of lipid under the
conditions of our solution studies may cause a large increase in binding affinity.
While all of the materials used in our laboratory’s AUC studies were obtained
from the Esmon laboratory, samples were subjected to additional purification
steps including gel filtration and dialysis. Oganesyan etal., state that removal
of phospholipid from the binding site could not be achieved by extensive
washing steps although it is unclear how they are detecting the presence of
bound lipid.

The goal of this work is to conduct a series of sedimentation velocity
experiments using the absorbance optics and FDS to study the effect of both
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phosphatidylethanolamine (DPPE) and phosphatidylcholine (DPPC) on the
interaction between rsEPCR and protein C. This would include performing runs
on each protein individually and then mixing them together in a 1:1 mole ratio in
the presence and absence of either lipid. We hope to demonstrate the
requirement for lipid to achieve the high affinity interaction measured on the
surface and to rectify the apparent discrepancy between the solution and
surface measurements.

Results:
A soluble recombinant form of the endothelial protein C receptor was received
as a gift from Eli Lilly. Figure 12 shows the c(S) distribution for 14 |jM rsEPCR
collected using the absorbance optics. These data fit to a S app of 2.63 (2.61,
2.66) and a Mapp of 31,524 (28,124; 43,224). In order to determine whether
DPPC can bind to rsEPCR, FDS sedimentation velocity experiments were
performed selectively following a synthetic DPPC labeled with nitrobenzoxadiazol (NBD) in the presence and absence of rsEPCR. The excitation
and emission spectra of the NBD-DPPC were measured in buffer using an
SLM-AB2 fluorimeter and revealed peaks at 453 nm and 544 nm respectively.
The laser in the FDS optics emits light at a wavelength of 488 nm. In an ideal
FDS experiment a fluorophore such as fluorescein, Oregon green or one of the
Alexa dyes would be used. To compensate for being outside the optimum
excitation range of the optics a relatively high concentration of fluorophore (400
nM) was used in the FDS experiments. It should be noted that in order to
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detect this fluorophore using the absorbance optics a concentration of 100 pM
NBD-DPPC would have to be used. No sedimentation was observed in a cell
containing NBD-DPPC alone (data not shown). Figure 12 shows the c(S)
distribution for 10 pM rsEPCR in the presence of 400 nM NBD-DPPC as
detected by the fluorescence optics. This data fit to a Sapp = 2.83 (2.81, 2.85).
These data show that NBD-DPPC binds to rsEPCR. The increase in
sedimentation coefficient may indicate that a conformational change is
occurring when NBD-DPPC binds to rsEPCR. However, it is also possible that
the difference is sedimentation coefficient is the result in the temperature being
un-calibrated in the FDS development system.
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Figure 12: Sedimentation velocity of 14 pM rsEPCR (squares) collected with
the absorbance optics and 10 pM rsEPCR + 400 nM NBD-DPPC (circles)
collected with the fluorescence optics.

47

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Discussion:
While this work is still in progress, these experiments demonstrate the
application of FDS to study interactions between proteins and small molecules
such as lipids and drugs. Selectively monitoring the lipid in the rsEPCR system
will enable direct confirmation of whether the lipid is a necessary component of
the high affinity rsEPCR/PC complex that otherwise would be difficult to
determine. In addition, tracer sedimentation of fluorescently tagged lipids
provides a means of studying lipid-protein interactions at concentrations below
the lipid critical micelle concentration. This is an area of study previously
inaccessible by AUC. The study of lipid-protein interactions by FDS-AUC will
be valuable for the study of G-protein coupled receptors and other membrane
bound proteins.

The next step in this series of experiments will be to sediment the
rsEPCR/DPPC complex in the presence of protein C selectively following the
sedimentation of the fluorescently tagged DPPC. Similar experiments will also
be done using a fluorescein tagged DPPE. There is evidence in the literature
for preference of DPPE over DPPC. Future work could also include a titration
of rsEPCR at a constant concentration of lipid thus enabling a measurement of
the binding affinity of DPPC/E for rsEPCR.
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Use of FDS to Study High Affinity Interactions

Example 2: The interaction between GFP and anti-GFP
Introduction:
One of the long term goals of the non-ideality research discussed in Chapter 3
is to study the impact of high concentrations of background molecules of
defined charge on protein-protein interactions. To take advantage of the FDS
optical system and the use of GFP as a tracer molecule we choose to pursue
the identification of a high affinity antibody to use as a model system.

Results:
A series of FDS sedimentation velocity experiments were performed with four
different monoclonal anti-GFPs from various vendors. In each of these
experiments the concentration of GFP was held constant while titrating the
antibody over a range of concentrations. The first two monoclonal antibodies
tested (Molecular probes and Zymed) did not appreciably bind to the GFP (data
not shown). The conclusion from this result was that these antibodies most
likely recognize internal epitopes that were unavailable for binding to the intact
GFP. This conclusion is consistent with the fact that both antibodies are
marketed for primary use in western blotting. The third antibody tested (BDclonetech) is marketed to work in both westerns and in immunocytochemistry.
An interaction between the BD antibody and GFP was not detected (data not
shown). This antibody apparently has a very low affinity. A fourth antibody
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(MBL), marketed to work in immunoprecipitation applications, was shown to
bind GFP in a 1:1 stoichiometry with high affinity (Figure 13).
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Figure 13: Sedimentation Velocity of 40 nM GFP titrated with 540 nM
(squares), 60 nM (circles), 20 nM (up triangles), 7 nM (down triangles) and 0.3
nM (diamonds) anti-GFP (MBL).

The mass fractions of free GFP and the GFP:anti-GFP complex were
determined by dividing the integrated areas of either the 2.6 S peak (GFP) or
the 7.8 S peak (GFP:Anti-GFP) by the total area under the c(s) distribution
curve. Plotting the mass fraction of the 7.8 S species and 2.6 S species as a
function of antibody concentration (Figure 14), shows a crossover point
occurring at approximately 20 nM, one-half of the total GFP concentration. This
result is indicative of quantitative binding. The concentration of GFP must be
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lowered in order to determine a binding constant for this interaction by
sedimentation velocity.
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Figure 14: Mass Fraction of 7.8 S (squares) and 2.6 S (circles) species as a
function of antibody concentration.

To further quantify the affinity of the GFP:anti-GFP interaction a fluorescence
polarization experiment was conducted monitoring the depolarization of GFP as
a function of antibody concentration (Figure 15). The Kd for this interaction is 1
nM.
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Figure 15: Direct binding of GFP to Anti-GFP as measured by fluorescence
polarization.

Discussion:
One of the noted advantages of the FDS optics is the dynamic range of
concentrations that can be examined. Specifically the ability to access low
concentrations should enable high affinity equilibrium constants to be measured
from centrifugation data. The Kd for the GFP-anti-GFP interaction was shown
to be 1 nM as measured by fluorescence polarization. The Kd for this
interaction could not be determined from the sedimentation velocity data due to
quanititative binding. In order to measure a Kd in the range of 1 nM the
concentration of the GFP would have to be lowered below 1 nM. At the time
these experiments were conducted the power of the laser did not allow us to
access the pM concentrations necessary to perform this type of analysis. The
current FDS optics system has remedied this problem.
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Another problem with this data set is that despite the concentration of GFP
being held constant in each of the samples, the total fluorescence intensity
varies from sample to sample. One potential explanation for the varying
fluorescence intensity could be poor laser focus. It is also possible that the
GFP is sticking to the windows or centerpieces causing differences in the total
sedimenting signal. Problems with laser focus can be remedied; however the
problem of fluorophores ‘sticking’ at low concentrations will always be a
potential pit-fall. There are multiple ways to reduce or remove ‘sticking’
including adding small amounts of detergent or BSA. It is likely that the remedy
will be unique for each system studied and therefore different additives should
be attempted to optimize the buffer conditions when studying high affinity
interactions at low protein concentration.

The goal of this work was to identify an interacting system that could be studied
in concentrated solutions of defined charge. Choosing a system such as the
GFP-anti-GFP interaction described here may not be ideal for these studies. A
system with a more moderate affinity would provide better access to the study
of the impact of the high concentration background solutions on the equilibrium
constant. The next step in this work will likely be to identify another associating
system for these studies.
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Use of FDS to Study Sedimentation in Physiological Media

Use of the FDS optical system enables the investigation of the sedimentation
behavior of tracer molecules in complex and concentrated solutions. An
example of an application of this type was discussed in Chapter 3 where FDS
was used to study the sedimentation of GFP in defined high concentration
background solutions. One of the goals of the experiments in Chapter 3 is to
bridge our understanding of the forces that are present in high concentration
solutions and how those forces impact the biochemical constants that we
measure in dilute solution relative to physiological conditions. In this section
several examples are given highlighting the use of FDS to study the
sedimentation of tracer molecules in biological media including human serum
and E. coli lysates.

Example 3: Sedimentation Velocity of Alexa488-BSA in Serum and in Plasma

In this set of experiments, sedimentation of 100 nM Alexa488-Bovine Serum
Albumin (Alexa488-BSA) was characterized in buffer, serum and in plasma
(Figure 16). The sedimentation of the Alexa488-BSA is slowed from Sapp = 5.2
(5.18, 5.21) in buffer to Sapp= 2.82 (2.82, 2.83) in serum and Sapp = 2.84 (2.83,
2.84) in plasma. All experiments conducted in serum and in plasma yielded
identical results. For this reason only the data collected in serum will be
discussed throughout the rest of this chapter.
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Figure 16: Sedimentation velocity of Alexa488-BSA in buffer (dotted line)
Serum (solid line) and Plasma (dashed line).

The concentration of albumin (HSA) in human blood ranges from 34 - 54 mg/ml.
Since BSA and HSA have similar masses it is likely that the Alexa488-BSA is
co-sedimenting with HSA and therefore experiencing a significant amount of
thermodynamic non-ideality as a result of both charge-charge repulsion and
excluded volume. In addition to thermodynamic non-ideality there is likely a
large degree of hydrodynamic non-ideality including the high viscosity and
density of serum. Human serum has a viscosity that is eight times that of water
(Altman, 1961). Serum contains a number of different macromolecules of
varying masses ranging from small lipoproteins such as HDL to large
macromolecules such as chylomicrons and antibodies. Both density and
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viscosity gradients will be formed radially as each of these macromolecules
sediments relative to its respective mass. These gradients complicate our
ability to correct for the hydrodynamic forces that are occurring in the velocity
cell. Further characterization will be needed to better understand sedimentation
velocity data collected in serum.

Qualitatively it appears that the relative proportions of Alexa488-BSA monomer
to dimer, assuming that the 5.2 S species in serum is dimer, are not affected in
the crowded environment. If the dimer were in reversible equilibrium with the
Alexa488-BSA monomer the amount of dimer might be expected to change due
to the non-ideality expected in serum. Since there is no change it is likely that
the dimer in the Alexa488-BSA sample is an incompetent byproduct of the
purification.

Example 4: Sedimentation of Alexa488-lqG in Serum

The graph in Figure 17 shows the c(s) fit for 500 nM Alexa488-lgG in buffer and
for 100 nM Alexa488-lgG in human serum. The data fit to Sapp = 6.49 (6.48,
6.52) and Sapp = 4.70 (4.67, 4.75) respectively. The valence of IgG is predicted
to be cationic, however, measured values in our laboratory have shown that the
actual valences of IgGs are closer to neutral, at pH 7.4, than expected from
calculations (Sue Chase, unpublished). The concentration of IgG in serum is
estimated to be between 10-30 mg ml"1 (Altman, 1961). As seen with the
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Alexa488-BSA it is likely that the Alexa488-lgG is co-sedimenting with IgGs
present in the serum. Since it is our prediction that the charge on these IgGs is
close to neutral it is unlikely that a high degree of charge-charge is occurring
with other serum components. Therefore, we would predict that the reduction in
sedimentation coefficient of the Alexa488-lgG is primarily due to hydrodynamic
non-ideality. This is supported by the observation that the percent reduction in
sedimentation coefficient is less for Alexa488-lgG (30%) versus Alexa488-BSA
(50%).
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Figure 17: c(s) fit for Alexa488-lgG in buffer (dotted line) and in serum (solid
line).

A comparison of the c(s) distribution for Alexa488-lgG in buffer versus serum
shows the presence of several additional peaks when the Alexa488-lgG is
spiked into serum. These two experiments were conducted six months apart so

57

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

it is possible that the small peak around 2.9 S is a degradation product. The
larger peak around 7.5 S could be indicative of IgG dimerization either induced
by the presence of serum or resulting from the age of the protein sample.

Example 5: Sedimentation of GFP in Human Serum

Figure 18 shows the raw data collected for 100 nM GFP in serum. The data
show complex boundary patterns that are likely the result of both
thermodynamic and hydrodynamic non-ideality. One interpretation of this type
of boundary pattern could be that the GFP is showing a Johnston-Ogston (JO)
effect (Johnston, (1946), Correia (1976)). JO effects occur when the
sedimentation boundary of one component lowers the sedimentation in the
presence of a second component. In this example, the sedimentation boundary
of macromolecules present in serum that are larger than GFP will move more
rapidly than the sedimentation boundary of the GFP. As a result the
concentration of the GFP will be higher in the region behind the boundary of the
faster sedimenting macromolecules and lower across the boundary of the faster
macromolecules. It is not expected that the JO effect would be dependant on
the concentration of the slower sedimenting component. However, a titration of
GFP into serum from 544 nM to 4 nM shows that the JO type peak can be
titrated (data not shown). Therefore it is likely that a second phenomenon is
occurring. The nature of this phenomenon remains to be investigated.
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Figure 18: Raw sedimentation velocity data for 100 nM GFP in human serum.

Panel A of Figure 19 shows the raw data for 4 nM GFP in human serum, as
mentioned above; there is no JO type peak at this concentration of GFP. The
corresponding c(s) fit to these data is shown in panel B of Figure 19. These
data fit to a Sapp = 2.41 (2.40, 2.41). The sedimentation coefficient for GFP in
buffer is S 2 o,w = 2.87 (2.85, 2.89)

Based on the total viscosity and density of

serum the sedimentation coefficient of GFP would be expected to be
significantly smaller that what is observed. These data suggest that the
sedimentation of GFP may be coupled to other macromolecules of opposite
charge as discussed in chapter 3. However, it is also likely that since GFP
sediments more slowly than either HSA or IgG, its boundary is moving in a
region of lower viscosity and density. The fact that GFP sediments more slowly
than these high-concentration proteins also makes it subject to the JO effect. It
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should be repeated; however, as discussed with the Alexa488-BSA and
Alexa488-lgG data, viscosity and density gradients that occur in serum as a
function of sedimentation complicate the interpretation of this result.
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Figure 19: Raw sedimentation data of 4 nM GFP in serum (panel A) and the
c(s) fit to the data (panel B).

Example 6: Sedimentation of the GFP-anti-GFP Complex in Serum

In these experiments a 1:1 mixture of GFP and anti-GFP (MBL) was spiked into
human serum at a concentration of 100 nM. The raw data for this experiment is
shown in panel A of Figure 20. Interestingly, despite being at a concentration of
100 nM GFP, we do not see the same JO type peak in this data set as
previously observed (Figure 18).

The c(s) fit to these data is shown in panel B

of Figure 20. The peak at Sapp = 2.37 (2.23, 2.38) is assumed to be free GFP
based on the data for GFP alone in serum. The second peak at Sapp 4.22 (4.21,
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4.22) is assumed to be the 1:1 complex between GFP and anti-GFP. The Kd
for this interaction is 1 nM (see example 2). The concentrations of GFP and
anti-GFP are 100-fold greater than the Kd, therefore it would be expected that
all of the GFP should be complexed with the anti-GFP under these conditions.
These data suggest that the equilibrium constant for this interaction is shifted to
a lower affinity in serum. This result is contrary to what would be expected
based on the excluded volume of serum. These data suggest that the enthalpic
environment of serum may be influencing the interaction between GFP and
anti-GFP. It is also possible that hydrodynamic non-ideality is influencing this
interaction. The next step in this work will be to perform a titration of the MBL
anti-GFP to determine the Kd for this interaction in serum.
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Figure 20: Raw sedimentation velocity data (panel A) and c(s) fit for 100 nM
GFP + 100 nM anti-GFP (panel B) in serum.
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Example 7: Sedimentation Velocity of Fluorescein-DPPE in Serum

Figure 21 shows the raw data for 2 pM fluorescein labeled DPPE sedimenting
in human serum. These data show at least one sedimenting boundary,
potentially a floating boundary and a JO type peak. The primary sedimenting
boundary is likely fluorescein-DPPE bound to HSA. An estimate of the
sedimentation coefficient for the primary sedimenting boundary can be
calculated using equation 1:
( 1)
w t
where r is the radial location of the midpoint of the sedimenting boundary, r is
the meniscus position and w2t is the angular velocity of the rotor. The apparent
sedimentation coefficient for this boundary is 2 S. This is smaller than what we
measured for Alexa488-BSA.

The floating boundary may be the result of the fluorescein-DPPE inserting into
lipid micelles present in the serum. Further experimentation will be necessary
to clearly identify all the phenemona occurring in these data. These data do
show however, the potential for studying small molecule interactions in serum.
One potential application could be for the study of HSA-drug interactions.
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Figure 21: Raw sedimentation velocity data for 2 pM fluorescein-DPPE in
human serum.

Example 8: Sedimentation of GFP in E. Coli Lysates

Sedimentation velocity experiments were conducted adding a constant amount
of GFP into a series of dilutions of e.coli lysate. The apparent sedimentation
coefficient of GFP is increased in the presence of the lysate relative to buffer
(Figure 22). These data do not take into account differences in viscosity and
density that will further magnify the increase in sedimentation coefficient. The
increase in sedimentation coefficient is dependent on the total concentration of
protein in the E. coli lysate (data not shown). The sedimentation coefficient
returns to the value measured in buffer as the concentration of lysate is
decreased. These data suggest that the sedimentation of GFP is coupling to
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other macromolecules in the lysate. Based on the observations discussed in
Chapter 3 it is likely that GFP is selectively sedimenting with macromolecules of
opposite charge present in the lysate.

15000

12000

(U

9000

6000

Sedimentation Coefficient

Figure 22: Sedimentation Velocity of 20 nM GFP in buffer (squares) and E. Coli
Lysate (circles).

Summary

This chapter has highlighted several applications of FDS in the analytical
ultracentrifuge. The application of FDS to answer biological questions is clearly
still in its infancy. The examples presented here have demonstrated that FDS
will enable the study of high affinity interactions in the AUC. With appropriate
laser power and choice of fluorophore very low concentrations of
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macromolecules can be detected. One of the remaining obstacles will be
reducing sticking when working with low concentration applications. Many
options exist for the treatment of sticking including the treatment of the cell
components will chemicals such as silicone or through optimization of the buffer
conditions. Time and experience will show which methods work the best.

This chapter has also highlighted several applications of tracer sedimentation
using FDS in the AUC. These examples have shown that these types of
experiments can yield very complicated boundary patterns. Much more data
will need to be collected to better understand the forces that manifest these
complicated boundary patterns. As our understanding of these forces builds
more sophisticated fitting software will need to be developed to more
completely capture all of the information in these data sets. In the meantime,
qualitative data can be gathered from the systems that will be useful in testing
basic theories and designing future experiments.
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APPENDIX A

MEASUREMENT OF STOKES RADIUS

The Stokes radius for three of the proteins used in this work was measured by
analytical ultracentrifugation. Measurement of the Stokes radius is necessary
for calculation of the charge of a macromolecule from electrophoretic mobility
data.

The Stokes radius can be calculated from the sedimentation coefficient of a
macromolecule as measured in a sedimentation velocity experiment. The
definition of the sedimentation coefficient is shown in equation 1:
s=m -v p )

Nf
where M is the molecular weight of the macromolecule, v is the partial specific
volume, p is the density of the solvent, N is Avogadro’s number and f is the
frictional coefficient. The frictional coefficient is defined in equation 2 as:
/

= 6 tttj0R

s

(2)

where q0 is the viscosity of the solvent and Rs is the Stokes radius of
macromolecule. The Stokes radius can be calculated directly from the
sedimentation coefficient if accurate values of M, v, p and q0 are known.
Measurement of the effective reduced molecular weight, a, by sedimentation

68

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX A continued

equilibrium alleviates the need to accurately determine the above listed
parameters. The effective reduced molecular weight is defined in equation 3
as:

a = M (\-vp W
RT
where M is the molecular weight, v is the partial specific volume, p is the density
of the solvent, u> is the angular velocity of the rotor, R is the gas constant and T
is the temperature. Dividing the sedimentation coefficient by the effective
reduced molecular weight and rearrangeing results in equation 4:

Rs =

° RT 2

SOTTTJq IIJ

<4>

Calculation of Rs by this method only requires the additional measurement or
calculation of solvent viscosity.

Sedimentation velocity experiments were conducted at 60,000 RPM and 20 °C
in a pH 7.5 buffer containing 10 mM Tris, 100 mM KCI and 0.5 mM EDTA. The
concentrations of GFP, Barstar and STI were 16 pM, 29 pM and 15 pM
respectively. Sedimentation was monitored by measuring the absorbance at
280 nm for each of the proteins. The non-interacting discrete species model in
SEDFIT version 8.9 (available online at www.analvticalultracenrifuqation.com1
was used to fit each of the data sets (Schuck, 2000). Confidence intervals
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APPENDIX A continued
(68.3%) on the sedimentation coefficient were calculated using the SEDFIT
software. The values for the sedimentation coefficients are listed in table 2.
Sedimentation equilibrium experiments were conducted in the same buffer
listed above using 6-channel charcoal-epon centerpieces. Data was collected
monitoring absorbance at 280 nm for Barstar and STI and at 485 nm for GFP at
three protein concentrations at 15,000, 20,000 and 35,000 RPM at 20 °C. The
data was analyzed using Winnonlin version 1.06 (available online at
www.bbri.org/RASMB/rasmb.htmn and the values for the fit effective reduced
molecular weights are listed in table 2.

The Stokes radius was calculated from the sedimentation coefficient and
effective reduced molecular weights using a calculated solvent viscosity
obtained using the program SEDNTERP (available online at
www.bbri.org/RASMB/rasmb.htmn based on the buffer components.

GFP
Barstar
Soybean Trypsin
Inhibitor

S
2.86 (2.84,
2.87)
1.52(1.51,
1.52)
2.16(2.14,
2.19)

a
0.86 (0.81, 0.92)
RMS =0.01
0.34 (0.32, 0.36)
RMS = 0.01
0.57(0.54, 0.61)
RMS =0.01

Rs x 10v
2.61
(2.48, 2.78)
1.94
(1.84, 2.05)
2.29
(2.19, 2.42)

Table 2: Apparent sedimentation coefficients, effective reduced molecular
weight and the calculated Stokes radius of GFP, Barstar and Soybean Trypsin
inhibitor.
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APPENDIX B

FDS OF GFP IN PEG, OVALBUMIN, RNASE A, HEL AND BARSTAR

The first experiment conducted to explore the role of charge in concentrated
solutions was performed using 50 mg ml'1 PEG, Ovalbumin and HEL (Figure
23). In this experiment lyophilized PEG, Ovalbumin and HEL were re
suspended in a pH 7.5 buffer containing 20 mM Tris, 100 mM KOI and 0.5 mM
EDTA. A concentration of 10 nM GFP was added to each of the 50 mg ml"1
background molecule stocks. Sedimentation velocity data was collected at 20
°C and 50,000 rpm using the FDS optics. The data were fit using the
continuous c(s) distribution model in Sedfit version 8.9.

In this experiment it was observed that while the sedimentation of GFP was
slowed in the presence of PEG and Ovalbumin there was an apparent increase
in sedimentation in the HEL solutions. This was the first piece of data alluding to
the importance of charge in concentrated solutions.
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Figure 23: c(s) distribution for 10 nM GFP in buffer (solid line), PEG (dashed
line), Ovalbumin (dotted line) and HEL (dash-dot line)

After this initial observation several changes were made to the experimental
design. As can be seen in Figure 23, PEG has a large effect on the
sedimentation of GFP. This is most likely due to the high viscosity of the 50 mg
ml'1 PEG solution. Therefore, the decision was made to replace PEG with
Dextran, a spherical macromolecule whose viscosity increment is more closely
matched to the charged protein background macromolecules. Additionally,
Ovalbumin was replaced with STI to avoid potential JO effects that are likely to
occur since the mass of Ovalbumin is greater than GFP. Switching to STI
allows our tracer molecule to remain in a constant enthalpic bath over the

72

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX B continued
course of the velocity experiment. It should also be noted that for all
subsequent FDS experiments in high concentration solutions the background
molecules were exhaustively dialyzed against buffer prior to adding the tracer
molecule.

Additional FDS velocity experiments were performed using proteins not
discussed in Chapter 3. These proteins include Barstar (anionic) and RNase A
(cationic). Barstar was chosen because it is small and relatively easy to
express in large quantities. Unfortunately, the laser focus and quality of the
data from the experiments where Barstar was used as the background
molecule are quite poor (data not shown) and therefore need to be repeated.
Experiments conducted using RNase A as the background molecule showed
that RNAse A can cause aggregation of GFP (data not shown). This is likely
due to a bad batch of RNAse A. These experiments should also be repeated.

The aggregation problem seen with the RNAse A is also a reminder of the
importance of choosing background molecules that are well characterized and
are not prone to aggregation at high concentrations. Each of the background
molecules used in the FDS experiments in Chapter 3 were characterized at
high concentration using the interference optics as well as under dilute
conditions using the absorbance optics (data not shown).
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APPENDIX C

SOLUTION DENSITIES AND PARTIAL SPECFIC VOLUME OF
BACKGROUND MOLECULES

Solution density. The solution density of each of the concentrated background
solutions was measured to enable conversion of apparent sedimentation
coefficients to

S 2o,w

values. Density measurements were made on a

Mettler/Paar Precision Density Meter DMA 02 D at 20°C in a buffer containing
10 mM Tris, pH 7.5, 100 mM KCI and 0.5 mM EDTA. The densitometer was
equilibrated for at least one hour prior to taking measurements. An initial
measurement of the density of air was recorded as the average of 15 readings
followed by water, buffer, samples, water and then a final air reading. All
samples were degassed prior to loading. The densitometer tube was
equilibrated for a minimum of 10 minutes after loading before density readings
were recorded. The tube was washed and dried with water and ethanol in
between loading samples.

In order to determine the solution densities it is first necessary to calculate the
apparatus constant for the densitometer using equation 1:
d , - < / 2 = t ( 7 ; 2 - r 22)

(D
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APPENDIX C continued
where di is the density of water, d2 is the density of air, T 1 is the period of
oscillation measured for water and T2 is the period of oscillation measured for
air (1). To calculate the apparatus constant, T 1 and T2 are calculated as the
average of the oscillation readings taking at the beginning and end of the
experiment and known values for the density of air and water under the
experimental conditions are substituted for di and d2. Once the apparatus
constant has been determined the density of each of the samples can be
calculated relative to the measured values for water.

Partial Specific Volume: The partial specific volume of a macromolecule is the
effective volume per unit mass of a macromolecule dissolved in a solution. The
apparent partial specific volume of a macromolecule can be determined
experimentally by plotting solution density as a function of macromolecule
concentration. The data are fit linearly and the slope of the line is used to
calculate the partial specific volume using equation 2:
v = L^S P ?

(2)

P s ,c = o

where ps,c=o is the solvent density at zero macromolecule concentration.

The results for HEL are shown in graph 24. The results for soybean trypsin
inhibitor are shown in graph 25. The results for Dextran are shown in Graph 26.
The results for Ovalbumin are shown in graph 27. The results for RNAse A are
shown in Graph 28.
75

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX C continued
Table 3 shows the measured partial specific volumes for each of the
macromolecules in addition to the equations to be used for calculating solution
density as a function of macromolecule concentration. The difference between
the measured values and values calculated using Sednterp (available online at
www.bbri.org/RASMB/rasmb.html) varies between 0.41 % for Soybean Trypsin
Inhibitor to 5.2 % for RNAse A.

The larger discrepancies in the partial specific volume measurements may
highlight inaccurate determination of the absolute protein concentration of these
solutions. For the case of RNAse A, multiple published values for the molar
extinction coefficient were found. The value ultimately chosen for determination
of concentration in this work may not accurately reflect the true composition of
the commercially purchased RNAse A. For the purposes of these studies
accurate values for the partial specific volumes of the background molecules is
not necessary for analysis. What are necessary are accurate measurements of
density for each solution at a given concentration.
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APPENDIX C continued
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Graph 24: Solution density plotted as a function of HEL concentration.
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Graph 25: Solution density plotted as a function of STI concentration.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX C continued

1.050 -j

i

|

i

|

i

-i-------1
-------1
-------1
-------1
-------1
-------1
-------

1.045-

-

1.040-

s *

-

1.035-

-

J

x /

1.030-

/

o
to
o

ity

O)
g 1.025(/)
c
£ 1.015Q

/

_

/

1.005-

0.995-

-

/■

1.010-

1.000-

/

w f

/

y

*

-

/

1

■

1

■

1

1

1

1

1

1

1

1

Concentration Dextran [g/ml]

Graph 26: Solution density plotted as a function of Dextran concentration.
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Graph 27: Solution density plotted as a function of Ovalbumin concentration.
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Graph 28: Solution density plotted as a function of RNAse A concentration.
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APPENDIX C continued

Equation to Calculate
Measured
Calculated Partial
Partial Specific
Density as a Function
Specific Volume
of Concentration
Volume [ml/g]
[ml/g] (Sednterp)
1.00362
n/a
n/a
Buffer
p = 1.00337 + 0.2680c
0.715
HEL
0.726 ±0.031
0.734
p = 1.00348 +
STI
0.731 +0.020
0.26562c
0.611
Dextran
p = 1.00369 +
0.629 ± 0.004
0.36921c
0.737
Ovalbumin
p = 1.00364 +
0.743 + 0.003
0.25418c
0.709
p = 1.00361 +
RNAse A
0.748 ± 0.001
0.24920c
Table 3: Densities and Partial Specific Volumes of Background Molecules

1. Kratky, O., Leopold, H., Stabinger, H. The Determination of the Partial
Specific Volume of Proteins by the Mechanical Oscillator Technique. Methods
in Enzymology. 1973; 27:98-110.
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APPENDIX D

SOLUTION VISCOSITIES OF BACKGROUND MACROMOLECULES

Solution viscosity: The solution viscosity of each of the concentrated
background solutions was measured to enable conversion of apparent
sedimentation coefficients to

S 2o,w

values. Viscosity measurements were made

on an Anton Paar microvisocometer. For each measurement 120 pi of the
concentrated background molecule solution was loaded into the viscometer
capillary tube. The corresponding measured density of the solution was entered
into the software and dynamic viscosity measurements were made at 70° (n =
4), 60° (n = 4) and 50° (n = 6). Measured viscosities were plotted as a function
of background molecule concentration and fit linearly to obtain an equation
enabling calculation of the solution viscosity at any given concentration.

Graph 291 shows the viscosity data for the HEL solutions, Graph 30 shows the
data for the STI solutions, Graph 31 shows the data for the Dextran Solutions,
Graph 32 shows the data for the Ovalbumin solutions, and Graph 33 shows the
data for the RNAse A solutions. Table 4 contains the equations to be used for
calculation of solution viscosity at any background macromolecule
concentration.
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Graph 29: Solution viscosity plotted as a function of HEL concentration.
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Graph 30: Solution viscosity plotted as function of STI concentration.
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Graph 31: Solution viscosity plotted as a function of Dextran concentration.
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Graph 32: Solution viscosity plotted as a function of Ovalbumin concentration
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Graph 33: Solution viscosity plotted as a function of RNAse A concentration

Buffer
HEL
STI
Dextran
Ovalbumin
RNAse A

Equation to Calculate Viscosity as a Function
of Concentration
1.0051
H = 1.0016 + 0.00359c
H = 0.9917 + 0.00575c
q = 0.87705 + 0.01767c
q = 1.00078 + 0.00456c
n = 1.00055 + 0.00418c

Table 4: Equations for calculating density as a function of background
macromolecule concentration.
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APPENDIX E

ALEXA488-BSA IN VARIOUS HIGH CONCENTRATION BACKGROUNDS

In order to evaluate whether the phenemona described in Chapter 3 can be
generally applied, a series of FDS sedimentation velocity experiments were
conducted replacing GFP with Alexa488-BSA as the tracer molecule. In these
experiments Dextran, Ovalbumin and HEL were used as background molecules
at a concentration of 50 mg ml'1. Sedimentation velocity data was collected
using the FDS optics at 50,000 at 20 °C in a pH 7.5 buffer containing 10 mM
Tris, 100 mM KCI and 0.5 mM EDTA. The data were fit using the continuous
c(s) distribution model in Sedfit version 8.9.

Figure 34 shows the apparent sedimentation of Alexa488-BSA in Dextran,
Ovalbumin, HEL and buffer. The apparent sedimentation of the Alexa488-BSA
is slowed in the presence of Dextran and Ovalbumin relative to buffer. As with
the GFP experiments the effect of Dextran and Ovalbumin appears to be
primarily hydrodynamic. The apparent sedimentation of the Alexa488-BSA is
increased in the presence of HEL. In addition to the increase in the apparent
sedimentation coefficient of the Alexa488-BSA we also see the formation of
larger complexes and possible aggregates in the HEL background. The nature

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX E continued
and composition of these larger species will require further experimentation. In
the interim, these data support the conclusion that attractive non-specific
charge-charge interactions occur in crowded solutions.
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Figure 34: Sedimentation of Alexa488-BSA in buffer (solid black line), Dextran
(dashed line), Ovalbumin (dotted line) and HEL (dash-dot line).
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